Polaris prostate

The Prolaris® test from

Myriad Genetics

, the world’s leader in genetic testing, adds clinically proven information to traditional diagnostic tools like PSA and Gleason and spells out how fast your prostate cancer will progress. The Prolaris test helps you avoid overly aggressive treatments – or those that aren’t aggressive enough.

What is prostate Prolaris?

Prolaris is a genomic test that analyzes changes in 46 genes in prostate biopsy tissue. It generates a risk score to help predict the likelihood of disease progression in men with localized prostate cancer.

What is a prostate cancer test?

Prolaris for Prostate Cancer Patients. Prolaris is a genomic test developed to aid healthcare professionals in predicting prostate cancer aggressiveness in conjunction with clinical parameters such as Gleason score and PSA.

How is prostate cancer progression evaluated?

The risk of prostate cancer progression is currently evaluated based on the prostate-specific antigen (PSA) value, the Gleason score, and clinical factors. Examples of prediction models include the National Comprehensive Cancer Network risk group and a model that integrates clinical, PSA value, and biopsy data. 2 – 4

What is a prostate cancer test?

Prolaris for Prostate Cancer Patients. Prolaris is a genomic test developed to aid healthcare professionals in predicting prostate cancer aggressiveness in conjunction with clinical parameters such as Gleason score and PSA.

What is a Prolaris test?

Prolaris is a genetic test developed by Myriad that directly measures tumor cell growth. The Prolaris test paired with both PSA and Gleason provides the level of aggressiveness of a patient’s individual prostate cancer.

What is a prostate biopsy?

Prostate tissue sample from biopsy will be sent to Myriad. The tissue is tested and analyzed to determine the aggressiveness of the prostate cancer in question. Once the sample (s) have been processed, the results are sent directly to the physician.

How is Prolaris scored?

The Prolaris Score is calculated by directly measuring the biology of the tumor and how fast the cells in your tumor or dividing. Since you have already had a biopsy which determined that you have prostate cancer, that tissue sample can also be used to determine your Prolaris Score.